About
AmboVent is a device inspired by the bag-valve mask ventilators that paramedics use when manually ventilating patients in an ambulance. The device also provides controls for respiration rate, volume, and maximum peak pressure. AmboVent is being developed as part of a global partnership for the greater good, with an open-source code mentality and on a nonprofit basis, to enable free and simple mass production by anyone, anywhere in the world. It is designed as an automatic, controlled, alternative ventilation system for adults, for use only in emergency situations when no other approved ventilation machines are available. The AmboVent initiative is led by the Israeli Air Force (IAF) 108 electronic depot in partnership with Magen David Adom (MDA). The R&D phase was backed by a large community of innovators, including makers from First Robotics Israel (mentors and students); physicians from leading Israeli hospitals such as Tel Aviv Sourasky and Hadassah JLM as well as other medical centers; engineers from Haifa Technological Center and The Garage program by Microsoft Israel; IAF Unit 108; and others.
Company Intelligence Q&A
Structured intelligence from startupim data — optimized for AI retrieval and grounding.
- What is AmboVent's primary product?
- AmboVent's primary product is an emergency ventilation device inspired by bag-valve mask ventilators, designed to provide automatic, controlled ventilation for adults in emergency situations.
- When was AmboVent founded?
- AmboVent was founded in March 2020.
- What is AmboVent's current operational status?
- AmboVent is currently inactive, having ceased operations in April 2021.
- What is AmboVent's approach to its technology development and distribution?
- AmboVent is developed with an open-source code mentality and on a nonprofit basis, aiming to enable free and simple mass production globally.
- Which organizations lead the AmboVent initiative?
- The AmboVent initiative is led by the Israeli Air Force (IAF) 108 electronic depot in partnership with Magen David Adom (MDA).
- Which organizations contributed to AmboVent's R&D phase?
- The R&D phase for AmboVent was supported by First Robotics Israel, physicians from Tel Aviv Sourasky and Hadassah JLM hospitals, engineers from Haifa Technological Center and The Garage program by Microsoft Israel, and IAF Unit 108.
- What was a key news event for AmboVent in April 2020?
- In April 2020, AmboVent shared its open-source, build-it-yourself breathing machine to help address the global ventilator shortage.
- What is AmboVent's current funding stage?
- AmboVent is currently in the Pre-Funding stage.